Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

2647
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, Animal Health, and Others.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.

The Others segment includes all activities that do not qualify as reportable segments under IFRS 8 “Operating Segments”; it also includes the effects of retained commitments in respect of divested businesses.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 113 496 persons.
Sales per Businesses
201220132014
EUR (in Million)%EUR (in Million)%EUR (in Million)%
Pharmaceuticals28,87182.6%27,25082.7%27,72082.1%
Vaccines3,89711.2%3,71611.3%3,97411.8%
Animal Health2,1796.2%1,9856%2,0766.1%
Other------
Sales per Regions
201220132014
EUR (in Million)%EUR (in Million)%EUR (in Million)%
Other Countries12,45135.6%11,44134.7%11,45333.9%
United States10,87331.1%10,43331.7%11,33933.6%
Europe8,21023.5%7,93324.1%7,93223.5%
France2,8468.1%2,5717.8%2,4747.3%
North America567.001.6%573.001.7%572.001.7%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD592015Chief Executive Officer
Serge Weinberg642009Chairman
Jérôme Contamine582009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD642011President-Global Research & Development
Igor Landau712004Director
Robert Castaigne, PhD622000Independent Director
Jean-René Fourtou762004Independent Director
Claudie Haigneré MD, PhD582008Independent Director
Uwe Bicker PhD, MD702008Independent Director
Gérard van Kemmel, MBA762003Independent Director
Shareholders
NameShares%
L'Oréal SA 118,444,357 8.98%
Norges Bank Investment Management 29,478,279 2.23%
Dodge & Cox 21,616,402 1.64%
The Vanguard Group, Inc. 18,366,363 1.39%
Plan d'Epargne Entreprise Sanofi Synthelabo 17,075,788 1.29%
Amundi SA (Investment Management) 15,968,156 1.21%
Natixis Asset Management SA 12,886,425 0.98%
Sanofi 12,190,839 0.92%
BlackRock Fund Advisors 11,767,926 0.89%
Lyxor International Asset Management SAS 9,700,381 0.74%
Holdings
NameShares%Valuation
Regeneron Pharmaceuticals Inc (REGN) 22,859,14422.7%10,320,446,333 USD
Sanofi (SAN) 12,190,8390.92%1,203,635,913 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,051,60312.0%1,049,588,385 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%745,697,271 USD
Sanofi India Ltd (SANOFI) 13,909,58760.4%745,697,271 USD
Zentiva SA (ROSCD) 312,341,64974.9%130,708,733 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 2,846,0004.69%65,688,782 USD
Immune Design Corp (IMDZ) 917,4295.44%19,366,926 USD
GlycoMimetics Inc (GLYC) 1,084,2055.71%9,020,586 USD
Proteome Sciences plc (PRM) 46,0000.021%14,084 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
ACTAVIS PLC
BAYER AG
NOVO NORDISK A/S
GLAXOSMITHKLINE P..
BRISTOL-MYERS SQU..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
SHIRE PLC
REGENERON PHARMAC..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
CSL LIMITED
Sector Pharmaceuticals
Sanofi : Connections
Financière BFSA
Aventis Foundation
Alliance Automotive Group SAS
Weinberg Capital Partners SAS
Sanofi-Aventis Europe SAS
Institute of Medicine
Sanofi Aventis Participations SA
Montres CORUM Sàrl
Universcience.fr
Piasa SA
VL Holding (France)
Sanofi Pasteur Holding SA
The Children's Aid Society, Inc.
INSEAD
The Johns Hopkins University
Sanofi-Aventis U.S. LLC
Financières SASA
Fondation C.Génial
Bordeaux University Foundation
École Normale Supérieure
Piasa Holding
Pres héSam
Financière Piasa
Academie des Sports
Académie des Sciences et Technologies
Fondation de France
Mayo Clinic
L'Oréal Corporate Foundation
Lasker Foundation
Fondations René Lacoste
Research!America
Académie des Technologies
King Abdullah University of Science & Technology
Academie de l'air et de l'espace
Académie Nationale de Médecine
Philipps University of Marburg
National Academy of Engineering
Ruprecht-Karls-Universität Heidelberg
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- Euronext 100 / Stoxx Europe 50, CAC 40, CAC All Shares, EuroStoxx 50, FTSE Eurotop 100, CAC Large 60, CAC All-Tradable, Stoxx Global 200, Stoxx France 50
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF